Home » Tenders » Americas » USA » Tender 140265019

Notice of Intent to Sole Source Agilent Tender in USA - 140265019

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH has issued a Tender notice for the procurement of a Notice of Intent to Sole Source Agilent Technologies in the USA. This Tender notice was published on 28 Apr 2026 and is scheduled to close on 04 May 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 140265019, while the tender notice number is 26-000161 and Registering on the platform.

Procurement Summary

Country: USA

Summary: Notice of Intent to Sole Source Agilent Technologies

Deadline: 04 May 2026

Posting Date: 28 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 140265019

Document Ref. No.: 26-000161

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

This acquisition is for reagents and preventative maintenance for the Seahorse XFEe Analyzer at the National Institutes of Health (NIH) Clinical Center (CC) Center for Cellular Engineering.
• Product Service Code: 6515 - Medical Instruments, Equipment, and Supplies
• NAICS Code: 339112 - Surgical and Medical Instrument Manufacturing
• Place of Performance: Bethesda, MD 20892 USA
POTS: 26-000161
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to Agilent Technologies, located at 121 Hartwell Ave, Lexington, MA 02421, on a firm fixed price sole source award basis to provide reagents and preventative maintenance services to the National Institutes of Health.
The proposed vendor, Agilent technologies, provides the clinically approved platform for reagents, kits, and the respective instruments that may be used for patient care testing on clinical and research cellular products. Preventive maintenance is required to compliance with the manufacturer and FDA 21 CFR 211.67. The Seahorse XFe96 is a unique instrument that can help us measure cellular potency using metabolic activity following CAR T cell and other cell product of manufacturing. This instrument is needed to generate data that is required for the release of the cellular therapy product. Agilent technologies is the sole vendor that provides the periodic Preventive Maintenance (PM) for this type of device.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasona...
Notice ID: 26-000161

Department/Ind. Agency: health and human services, department of

Sub-tier: national institutes of health

Office: national institutes of health - cc

Product Service Code: 6515 - medical and surgical instruments, equipment, and supplies

NAICS Code: 339112 - Surgical and Medical Instrument Manufacturing

Inactive Dates: may 19, 2026

Inactive Policy: 15 days after response date

Documents

Tender Notice

Browse More

All Tenders From USA

All Tenders From Americas

Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA

Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services

View Tenders By